Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-12-10Clinical Trial Update: Rehabilitation in Chronic Obstructive Pulmonary Disease (COPD) Patients With Emphysema
The clinical trial evaluating rehabilitation for patients with chronic obstructive pulmonary disease and emphysema has completed.
-
CLINICAL_TRIALS research · 2014-12-08Clinical Trial Update: An Investigation of the Mechanism of Action of Seretide in Chronic Obstructive Pulmonary Disease [Phase 4]
Phase 4 study investigating the mechanism of action of Seretide (fluticasone propionate/salmeterol) in chronic obstructive pulmonary disease…
-
CLINICAL_TRIALS trial_result · 2014-12-08Clinical Trial Update: Chronic Obstructive Pulmonary Disease (COPD) Nutrition Support Trial [NA]
Completed clinical trial evaluating nutrition support in patients with chronic obstructive pulmonary disease and malnutrition.
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: ADESPI: Adherence to Spiriva® in Patients With COPD (Chronic Obstructive Pulmonary Disease), Measured by Morisky-8 (MMAS-8) Scale, in Routine Medical Practice
A completed clinical trial evaluating adherence to Spiriva (tiotropium) in COPD patients in routine medical practice using the MMAS-8 scale;…
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Prognosis Value of Pro-adrenomedullin in Acute Exacerbations of COPD in ER [NA]
A completed clinical trial evaluating whether pro-adrenomedullin can prognosticate outcomes in patients with acute exacerbations of chronic …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Ambulatory Oxygen Effects on Muscles in COPD [Phase 4]
This Phase 4 trial from the University of Birmingham studied the effects of ambulatory oxygen on muscle function in people with chronic obst…
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Whole Body Vibration in Chronic Obstructive Pulmonary Disease (COPD) Patients [NA]
Trial update NCT01649310 investigates whole body vibration as an intervention for chronic obstructive pulmonary disease, with no results or …
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Web-based, Interactive Professional Education for Chronic Obstructive Pulmonary Disease
The trial evaluated a web-based, interactive education program for primary care clinicians regarding chronic obstructive pulmonary disease a…
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Pulmonary Disease in Patients Referred for Coronary CT
This entry reports the completion of a clinical trial studying pulmonary disease in patients referred for coronary CT, sponsored by Universi…
-
CLINICAL_TRIALS research · 2014-12-02Clinical Trial Update: Research to Evaluate a Possible Relation Between Values Obtained After Processing CT Images, Lung Function Tests and the Experience of the Patient During an Exacerbation in COPD Patients. [NA]
A completed clinical trial investigating whether values from CT image processing and lung function tests relate to patient experience during…
-
CLINICAL_TRIALS trial_result · 2014-11-25Clinical Trial Update: Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 trial updating results on adding umeclidinium bromide to fluticasone furoate/vilanterol versus placebo added to fluticasone furoate/…
-
CLINICAL_TRIALS research · 2014-11-21Clinical Trial Update: Evaluation of Reactive Oxygen Metabolites in the Value of COPD
Clinical trial update evaluating reactive oxygen metabolites as biomarkers in chronic obstructive pulmonary disease; no results or current s…
-
CLINICAL_TRIALS trial_result · 2014-11-20Clinical Trial Update: Safety, Tolerability and Pharmacokinetics (PK) of RV1162 in Healthy Subjects and COPD Patients [Phase 1]
A Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of RV1162 in healthy volunteers and COPD patients, with study stat…
-
CLINICAL_TRIALS trial_result · 2014-11-18Clinical Trial Update: A Collection of Vital Status and Pulmonary Medication Usage Data for Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Withdrew Prematurely From Tiotropium Inhalation Solution Delivered by the Respimat Inhaler
A study update presenting vital status and pulmonary medication usage data for COPD patients who prematurely withdrew from tiotropium inhala…
-
CLINICAL_TRIALS trial_result · 2014-11-17Clinical Trial Update: Efficacy and Safety of QMF149 vs. Salmeterol Xinafoate/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]
A Phase 2 trial comparing QMF149 to salmeterol/fluticasone in COPD completed with results posted, assessing efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2014-11-17Clinical Trial Update: Long-Term Study of the Effects of Navarixin (SCH 527123, MK-7123) in Participants With Moderate to Severe COPD (MK-7123-019) [Phase 2]
Phase 2 long-term study of navarixin (MK-7123) in moderate to severe COPD was terminated with results posted in 2014.
-
FDA approval · 2014-11-14FDA Approved: FLUTICASONE PROPIONATE HFA — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Fluticasone Propionate HFA submitted by Prasco Laboratories, confirming a regulatory change for …
-
CLINICAL_TRIALS trial_result · 2014-11-14Clinical Trial Update: Efficacy, Safety and Tolerability of the Co-administration of NVA237 Plus Indacaterol Once Daily Versus Indacaterol Once Daily in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 trial evaluating co-administration of umeclidinium (NVA237) and indacaterol once daily versus indacaterol alone in moderate-to-sever…
-
FDA approval · 2014-11-13FDA Approved: ADVAIR HFA — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for Advair HFA, the combination inhaled therapy of fluticasone propionate and salmeterol xinafoa…
-
FDA approval · 2014-11-13FDA Approved: FLUTICASONE PROPIONATE DISKUS — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Fluticasone Propionate Diskus by Prasco Laboratories.
-
FDA approval · 2014-11-13FDA Approved: ADVAIR DISKUS — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Advair Diskus (fluticasone propionate and salmeterol) from GlaxoSmithKline LLC under NDA 021077.
-
CLINICAL_TRIALS research · 2014-11-13Clinical Trial Update: Effects of NAVA and PSV to AECOPD Patients' Air Distribution and Dead Space [Phase 3]
A Phase 3 clinical trial evaluating neurally adjusted ventilatory assist (NAVA) and pressure support ventilation (PSV) on air distribution a…
-
CLINICAL_TRIALS trial_result · 2014-11-13Clinical Trial Update: Acute Effect of Pulmonary Desufflation on Cardiac Performance in COPD Patients [Phase 4]
This update reports findings from a Phase 4 trial evaluating the acute effect of pulmonary desufflation on cardiac performance in COPD patie…
-
CLINICAL_TRIALS trial_result · 2014-11-11Clinical Trial Update: Improving the Quality of End-of-Life Communication for Patients With Chronic Obstructive Pulmonary Disease (COPD) [NA]
A completed clinical trial focused on improving end-of-life communication for patients with COPD, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-11-11Clinical Trial Update: Impact of Roflumilast on Visceral Adiposity and Metabolic Profile in Chronic Obstructive Pulmonary Disease [Phase 2]
Phase 2 trial evaluating roflumilast for visceral adiposity and metabolic parameters in chronic obstructive pulmonary disease with metabolic…